Catalyst Award Advisors

Jonathan Fox MD, PhD

Chief Medical Officer, MyoKardia, Inc.

Stephen Freedman PhD

Vice President for Corporate Liaison and Ventures, Gladstone Institutes

Robert Garland MD, MBA, MPH

Partner, New Enterprise Associates

Michi Garrison MS

R&D Executive, Medical Device Industry

Snow Ge PhD

Senior Director, Nektar Therapeutics

Bruce Gingles

Vice President, Cook Medical

Cindy Glass

Strategic Advisor, Jackdaw Rock

Mark Goldstein

UCSF Health Hub Chairman

Marlene Grenon MD

Associate Professor of Surgery, UCSF

Donna Johnson Gressler PhD

Patent Agent and Principal, Petra Patent LLC

Michael Gropper MD, PhD

Professor, Anesthesia, UCSF

Daniel Haders PhD

Managing Director Healthcare Technology, Nex Cubed

Operating Partner, Sway Ventures

Lisa Hammitt

CEO, Beseeq

Scott Hammond MD

Chief Medical Officer, Corporate Secretary Director of Translational Medical Research Laboratory, UCSB

Karl Handelsman MBA, MS

Investment Director, Roche Venture Fund

Elisa Harvey PhD, DVM

Senior Regulatory Consultant, CardioMed Device Consultants

Joel Hayflick PhD

Senior Director Biologics Portfolio Strategy and Development, Teva Pharmaceuticals

Priti Hegde PhD

Anti-angiogenesis and Cancer Immunotherapy Franchises biomarker Lead, Oncology Biomarkers, Genentech

Joseph J. Higgins MD, FAAN

Medical Director, Neurology, Quest Diagnostics

Syed Hossainy PhD

Director of the Innovation Incubator, Abbott Vascular

Eric Hsia

Venture Partner, Translink Capital

Ed Hurwitz JD, MBA

Investment Team, MPM Capital

David Hutton PhD

Founder and Principal, Hutton Associates

Laurence Hyman JD, MS

Of counsel, canady + lortz LLP, Principal, Hyman IP Law

Sean Ianchulev MD, MPH

Chief Medical Officer, Transcend Medical, Inc.

Scott Iyama

Partner, Orrick’s Emerging Companies Group

Ricardo Izurieta MD, Dr.PH, MPH

Associate Professor, Global Health, USF

John Jacobsen PhD

Vice President, Chemistry, DiCE Molecules

Angelika Jahreis PhD, MD

Associate Group Medical Director, Genentech

 

Chris Jones MSE

Consultant

Jeff Jonker JD, MLitt

President, NGM Biopharmaceuticals

Sara Kenkare-Mitra PhD

Senior Vice President of Development Sciences, R&D, Genentech

Giulia C. Kennedy PhD

Chief Scientific and Medical Officer

H. Michael Keyoung MD, PhD

Managing Partner, Portola Capital Partners LLC, President, Catalyst Biosciences Asia

Shireen S. Khan PhD

Director of Biologics, ChemPartner

David Kim MD, MBA

CEO, DigiTx Partners

Pamela Klein MD

Oncologist - Independent Biotech/Pharma Consultant/Drug Development Strategy , PMK BioResearch

Andrei Konradi PhD

Principal, Konradi Molecular

Sanjay Kumar MD, PhD

Professor and Associate Chair, Department of Bioengineering, UC Berkeley

Richard Lawn PhD

Consulting Professor, Stanford University, School of Medicine

Kirby Lee PharmD, MA

Associate Professor of Clinical Pharmacy, UCSF

Pages